ATRC
AtriCure, Inc.Company Information
- Company Name
- AtriCure, Inc.
- CIK
- CIK0001323885
- Category
- Large accelerated filer
- Ticker: Exchange
- ATRC: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- ATRC
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-05-30
- Last sale
- 2026-09-23
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 101,001
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 51,125,993
- Shares outstanding
- 48,667,000
- Ownership
- 105.05%
Earnings Market Reaction
- Filing date
- 2026-07-27
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 168 | 146 | 167 | 148 | 118 | 100 | 123 | 130 | 106 | 65 | 84 | 81 | ||||||
| Accounts Receivable Net Current | 80 | 71 | 67 | 63 | 66 | 63 | 60 | 55 | 56 | 55 | 53 | 52 | ||||||
| Short Term Investments | - | - | - | - | - | - | 0 | 0 | 8 | 41 | 53 | 52 | ||||||
| Inventory Net | 84 | 81 | 78 | 79 | 76 | 75 | 75 | 77 | 74 | 72 | 68 | 62 | ||||||
| Prepaid Expense And Other Assets Current | 14 | 15 | 10 | 11 | 11 | 13 | 9 | 7 | 10 | 12 | 9 | 6 | ||||||
| Assets Current | 346 | 314 | 323 | 301 | 271 | 251 | 268 | 269 | 253 | 245 | 266 | 253 | ||||||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 42 | 40 | 39 | 40 | 41 | 41 | 42 | 44 | 42 | 42 | 42 | 41 | ||||||
| Long Term Investments | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Operating Lease Right Of Use Asset | 6 | 6 | 7 | 7 | 7 | 7 | 6 | 6 | 4 | 4 | 4 | 4 | ||||||
| Intangible Assets Net Excluding Goodwill | 43 | 46 | 48 | 50 | 52 | 54 | 56 | 58 | 60 | 62 | 64 | 66 | ||||||
| Goodwill | 235 | 235 | 235 | 235 | 235 | 235 | 235 | 235 | 235 | 235 | 235 | 235 | ||||||
| Other Assets Noncurrent | 5 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | ||||||
| Assets | 677 | 644 | 654 | 635 | 609 | 592 | 609 | 615 | 597 | 592 | 614 | 600 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 36 | 31 | 25 | 25 | 26 | 25 | 25 | 32 | 27 | 29 | 27 | 25 | ||||||
| Accrued Liabilities Current | 43 | 40 | 53 | 49 | 40 | 33 | 46 | 40 | 32 | 30 | 45 | 37 | ||||||
| Other Liabilities Current | 3 | 3 | 3 | 3 | - | - | 3 | - | - | - | - | 21 | ||||||
| Liabilities Current | 82 | 73 | 82 | 78 | 69 | 61 | 73 | 74 | 61 | 61 | 75 | 83 | ||||||
| Long Term Debt Noncurrent | 61 | 61 | 62 | 62 | 62 | 62 | 62 | 62 | 62 | 62 | 61 | 42 | ||||||
| Finance Lease Liability Noncurrent | - | - | - | - | - | - | - | - | - | - | 8 | 8 | ||||||
| Long Term Debt And Capital Lease Obligations Current | - | - | - | - | - | - | 3 | - | - | - | 3 | - | ||||||
| Other Liabilities Noncurrent | 7 | 7 | 7 | 7 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Liability Noncurrent | - | - | - | - | - | - | - | - | - | - | 3 | 3 | ||||||
| Liabilities | 160 | 152 | 162 | 159 | 144 | 137 | 148 | 150 | 135 | 135 | 148 | 137 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 920 | 905 | 905 | 891 | 878 | 863 | 864 | 851 | 841 | 827 | 824 | 812 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 1 | 1 | 1 | -0 | -1 | -0 | -1 | -1 | -1 | -2 | ||||||
| Retained Earnings Accumulated Deficit | -404 | -413 | -413 | -415 | -415 | -409 | -402 | -386 | -378 | -370 | -357 | -347 | ||||||
| Stockholders Equity | 516 | 492 | 492 | 477 | 464 | 455 | 461 | 465 | 462 | 456 | 466 | 463 | ||||||
| Liabilities And Stockholders Equity | 677 | 644 | 654 | 635 | 609 | 592 | 609 | 615 | 597 | 592 | 614 | 600 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | ||||||
| Common Stock Shares Issued | 51 | 51 | 50 | 50 | 50 | 49 | 49 | 49 | 49 | 48 | 48 | 47 | ||||||
| Shares Outstanding | 51 | 51 | 50 | 50 | 50 | 49 | 49 | 49 | 49 | 48 | 48 | 47 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialAtriCure, Inc. (ATRC) — SEC Financial Statements & Analysis
AtriCure, Inc. (ATRC) is a surgical & medical instruments & apparatus company, incorporated in DE. AtriCure, Inc. trades on Nasdaq as: ATRC. AtriCure, Inc. (ATRC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-27. Based on that filing, AtriCure, Inc. carries a market cap of $1.36B, a P/E ratio of 129.05x, a P/B ratio of 2.64x, a P/S ratio of 2.39x, an enterprise value of $1.25B, and an EV/EBITDA multiple of 50.69x. On profitability, it posts a gross margin of 76.30%, an operating margin of 2.26%, a net margin of 1.85%, a Return on Equity (ROE) of 2.15%, a Return on Assets (ROA) of 1.64%, and a Return on Invested Capital (ROIC) of 2.68%. Per share, it reports EPS of $0.22, diluted EPS of $0.22, free cash flow per share of $1.09, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 13.94% year-over-year, net income growth of -129.02% year-over-year, and EPS growth of -128.46% year-over-year. On the balance sheet, it maintains a current ratio of 4.22x, a quick ratio of 3.02x, working capital of $263.62M, a debt-to-equity ratio of 0.31x, a debt ratio of 0.24, an interest coverage ratio of 2.29x, free cash flow of $53.11M (TTM), and net debt of $-106.79M. Figures sourced from SEC EDGAR.
- Market Cap
- $1.36B
- P/E TTM
- 129.05x
- EPS TTM
- $0.22
- P/B TTM
- 2.64x
- ROE TTM
- 2.15%
- ROA TTM
- 1.64%
- Debt To Equity
- 0.31x
- Free Cash Flow TTM
- $53.11M
- Net Revenue TTM Growth 1Y
- 13.94%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is AtriCure, Inc. in?
AtriCure, Inc. (ATRC) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does ATRC trade on?
AtriCure, Inc. (ATRC) trades on the Nasdaq.
Where is AtriCure, Inc. incorporated?
AtriCure, Inc. is incorporated in DE.
When was AtriCure, Inc. (ATRC)'s most recent SEC filing?
AtriCure, Inc. (ATRC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-27.
What is ATRC's market cap?
AtriCure, Inc. (ATRC) has a market capitalization of $1.36B as of 2026-06-30.
What is ATRC's P/E ratio?
AtriCure, Inc. (ATRC)'s trailing twelve month P/E ratio is 129.05x as of 2026-06-30.
What is ATRC's EPS (earnings per share)?
AtriCure, Inc. (ATRC)'s trailing twelve month EPS is $0.22 as of 2026-06-30.
What is ATRC's ROE (return on equity)?
AtriCure, Inc. (ATRC)'s trailing twelve month Return on Equity (ROE) is 2.15% as of 2026-06-30.
What is ATRC's ROA (return on assets)?
AtriCure, Inc. (ATRC)'s trailing twelve month Return on Assets (ROA) is 1.64% as of 2026-06-30.
What is ATRC's ROIC (return on invested capital)?
AtriCure, Inc. (ATRC)'s trailing twelve month Return on Invested Capital (ROIC) is 2.68% as of 2026-06-30.
What is ATRC's EV/EBITDA?
AtriCure, Inc. (ATRC)'s trailing twelve month EV/EBITDA is 50.69x as of 2026-06-30.